← board
RMHI
distress 4/10 · elevated risk$0.980%today-65% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
—
Shares 1y
+1677%
Price & events
-59.7% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-1.6%
1W
+14.4%
1M
-1.6%
3M
-59.7%
6M
+15.1%
1Y
-69.2%
2Y
-95.8%
5Y
-95.1%
All
Overview
- Market Cap
- $77.11M
- Volume
- 0
- 52 Week Range
- $0.65 – $2.85
- Total Shares
- 78.36M
- % Held by Insiders
- 0.87%
- % Held by Institutions
- 0.00%
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 78,363,567 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.